J
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076
Price:
31.93
CNY
2.8%
Market Closed
Market Cap:
¥10.1B
Cash Flow Statement
Cash Flow Statement
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
Currency: CNY
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Stock-Based Compensation |
6
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
0
|
0
|
0
|
31
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
7
|
6
|
7
|
11
|
11
|
11
|
25
|
36
|
29
|
26
|
2
|
(13)
|
(8)
|
(2)
|
12
|
2
|
(19)
|
6
|
(2)
|
(10)
|
|
| Change in Working Capital |
(160)
|
(187)
|
(161)
|
(171)
|
(172)
|
(187)
|
(206)
|
(217)
|
(254)
|
(269)
|
(304)
|
(328)
|
(335)
|
(399)
|
(427)
|
(443)
|
(440)
|
(518)
|
(488)
|
(518)
|
|
| Cash from Operating Activities |
141
N/A
|
165
+17%
|
245
+48%
|
173
-29%
|
181
+4%
|
168
-7%
|
80
-53%
|
33
-58%
|
29
-13%
|
173
+489%
|
217
+26%
|
280
+29%
|
350
+25%
|
284
-19%
|
376
+32%
|
382
+2%
|
400
+5%
|
467
+17%
|
518
+11%
|
517
0%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(111)
|
(112)
|
(128)
|
(207)
|
(233)
|
(337)
|
(387)
|
(383)
|
(438)
|
(391)
|
(460)
|
(551)
|
(661)
|
(729)
|
(741)
|
(877)
|
(1 090)
|
(1 276)
|
(1 449)
|
(1 464)
|
|
| Other Items |
(52)
|
12
|
(335)
|
(36)
|
(4)
|
(31)
|
293
|
(1)
|
(11)
|
(101)
|
(1)
|
(28)
|
(2)
|
(194)
|
(256)
|
(147)
|
(303)
|
105
|
9
|
(23)
|
|
| Cash from Investing Activities |
(163)
N/A
|
(100)
+39%
|
(464)
-365%
|
(244)
+47%
|
(237)
+3%
|
(369)
-56%
|
(94)
+75%
|
(384)
-309%
|
(450)
-17%
|
(492)
-9%
|
(461)
+6%
|
(579)
-26%
|
(662)
-14%
|
(923)
-39%
|
(998)
-8%
|
(1 024)
-3%
|
(1 393)
-36%
|
(1 171)
+16%
|
(1 440)
-23%
|
(1 487)
-3%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
23
|
0
|
36
|
36
|
|
| Net Issuance of Debt |
52
|
(2)
|
(218)
|
(194)
|
(180)
|
(96)
|
255
|
256
|
261
|
295
|
125
|
190
|
696
|
752
|
881
|
1 073
|
807
|
773
|
1 040
|
1 310
|
|
| Cash Paid for Dividends |
0
|
0
|
(5)
|
(5)
|
0
|
0
|
(35)
|
(37)
|
(41)
|
(44)
|
(56)
|
(56)
|
(58)
|
(60)
|
(105)
|
(131)
|
(119)
|
(124)
|
(225)
|
(212)
|
|
| Other |
(13)
|
(13)
|
721
|
719
|
715
|
716
|
(12)
|
8
|
17
|
17
|
16
|
(3)
|
(7)
|
(8)
|
15
|
14
|
89
|
89
|
31
|
116
|
|
| Cash from Financing Activities |
40
N/A
|
(15)
N/A
|
498
N/A
|
520
+4%
|
535
+3%
|
620
+16%
|
215
-65%
|
233
+8%
|
237
+2%
|
268
+13%
|
85
-68%
|
131
+54%
|
632
+382%
|
685
+8%
|
791
+15%
|
957
+21%
|
800
-16%
|
760
-5%
|
880
+16%
|
1 250
+42%
|
|
| Change in Cash | |||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(8)
|
(8)
|
(8)
|
(4)
|
(2)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
1
|
(0)
|
8
|
8
|
6
|
7
|
|
| Net Change in Cash |
10
N/A
|
43
+328%
|
270
+531%
|
445
+65%
|
477
+7%
|
418
-12%
|
200
-52%
|
(118)
N/A
|
(184)
-56%
|
(52)
+72%
|
(162)
-209%
|
(171)
-6%
|
317
N/A
|
43
-86%
|
170
+294%
|
315
+86%
|
(185)
N/A
|
64
N/A
|
(36)
N/A
|
286
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
30
N/A
|
54
+79%
|
116
+116%
|
(34)
N/A
|
(53)
-54%
|
(169)
-222%
|
(307)
-81%
|
(349)
-14%
|
(409)
-17%
|
(218)
+47%
|
(244)
-12%
|
(271)
-11%
|
(310)
-14%
|
(445)
-44%
|
(365)
+18%
|
(495)
-35%
|
(690)
-40%
|
(809)
-17%
|
(931)
-15%
|
(947)
-2%
|
|
Switch to:
Switch to:
See Also
Discover More
